Attached files
file | filename |
---|---|
EX-31.2 - Shengtai Pharmaceutical, Inc. | v211171_ex31-2.htm |
EX-32.1 - Shengtai Pharmaceutical, Inc. | v211171_ex32-1.htm |
EX-31.1 - Shengtai Pharmaceutical, Inc. | v211171_ex31-1.htm |
10-Q - Shengtai Pharmaceutical, Inc. | v211171_10q.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of Shengtai Pharmaceutical, Inc., the
“Company,” on Form 10-Q for the quarter ended December 31, 2010, as filed with
the Securities and Exchange Commission on the date hereof, the “Report,” I,
Yongqiang Wang, Principal Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
February 14, 2011
|
/s/
Yongqiang
Wang
|
Yongqiang
Wang
|
|
Title:
Financial Controller
|
|
(Principal
Financial Officer)
|